2019
DOI: 10.26226/morressier.5d1a037657558b317a14067d
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Therapeutic Monitoring of Mood Stabilizers in Bipolar Disorder : Lithium and Anticonvulsants

Abstract: Atypical antipsychotics are widely used in the treatment of bipolar disorder. 1 Lurasidone is one of the medications approved by the Food and Drug Administration for the treatment of bipolar depression, both as adjunct and monotherapy. 2 Similar to other medications in its class, lurasidone has been reported to induce mania in patients being treated for bipolar depression. 3,4 We present a case series of 4 patients that developed acute mania with lurasidone, an effect that appears to be dose-dependent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 5 publications
(5 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?